| Literature DB >> 22056078 |
Ga Bin Park1, Yeong Seok Kim, Hyun-Kyung Lee, Hyunkeun Song, Seonghan Kim, Dae-Ho Cho, Dae Young Hur.
Abstract
Salubrinal is a specific eIF2α phosphatase inhibitor that inhibits ER stress-mediated apoptosis. However, maintaining hyper-phosphorylated eIF2α state with high doses of salubrinal treatment promotes apoptosis in some cancer cells. In this report, we found that salubrinal induced apoptosis of EBV-transformed B cells. Notably, salubrinal induced ROS generation and p38 MPAK activation, which then induced expression of FasL. Moreover, salubrinal subsequently led to activation of caspases, calcium redistribution, Bax translocation, cytochrome c release, and apoptosis. These findings suggest that salubrinal may be a novel therapeutic approach for EBV-associated malignant diseases.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22056078 DOI: 10.1016/j.canlet.2011.09.011
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679